DE60041556D1 - Verfahren zur peptidherstellung - Google Patents

Verfahren zur peptidherstellung

Info

Publication number
DE60041556D1
DE60041556D1 DE60041556T DE60041556T DE60041556D1 DE 60041556 D1 DE60041556 D1 DE 60041556D1 DE 60041556 T DE60041556 T DE 60041556T DE 60041556 T DE60041556 T DE 60041556T DE 60041556 D1 DE60041556 D1 DE 60041556D1
Authority
DE
Germany
Prior art keywords
peptide
cationic
amino acids
sectors
sector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60041556T
Other languages
English (en)
Inventor
Oeystein Rekdal
John Sigurd Svendsen
Mari Wikman
Terese Solstad
Nannan Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lytix Biopharma AS
Original Assignee
Lytix Biopharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB1999/002851 external-priority patent/WO2000012542A2/en
Application filed by Lytix Biopharma AS filed Critical Lytix Biopharma AS
Application granted granted Critical
Publication of DE60041556D1 publication Critical patent/DE60041556D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Semiconductor Lasers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60041556T 1999-08-31 2000-08-31 Verfahren zur peptidherstellung Expired - Lifetime DE60041556D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/GB1999/002851 WO2000012542A2 (en) 1998-08-28 1999-08-31 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
GBGB0005702.6A GB0005702D0 (en) 2000-03-09 2000-03-09 Method
PCT/GB2000/003378 WO2001019852A2 (en) 1999-08-31 2000-08-31 Methods of peptide preparation

Publications (1)

Publication Number Publication Date
DE60041556D1 true DE60041556D1 (de) 2009-03-26

Family

ID=9887296

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60041556T Expired - Lifetime DE60041556D1 (de) 1999-08-31 2000-08-31 Verfahren zur peptidherstellung

Country Status (14)

Country Link
US (1) US7393824B1 (de)
EP (1) EP1259536B1 (de)
JP (1) JP4902919B2 (de)
AT (1) ATE422502T1 (de)
AU (1) AU781243B2 (de)
CA (1) CA2382544A1 (de)
CY (1) CY1109450T1 (de)
DE (1) DE60041556D1 (de)
DK (1) DK1259536T3 (de)
ES (1) ES2322228T3 (de)
GB (1) GB0005702D0 (de)
NO (1) NO330170B1 (de)
PT (1) PT1259536E (de)
WO (1) WO2001019852A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB0005703D0 (en) * 2000-03-09 2000-05-03 Alpharma As Compounds
NO20031818D0 (no) * 2003-04-23 2003-04-23 Uni I Tromsoe Fremgangsmåte av bioaktiv peptid forberedelse
KR20080033331A (ko) * 2005-07-05 2008-04-16 바이오템프트, 비.브이. 종양 치료제
EP1864692A1 (de) 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
ES2633453T3 (es) 2008-01-24 2017-09-21 Esperance Pharmaceuticals Constructos de fusión de dominios líticos y métodos de preparación y utilización de los mismos
GB0821616D0 (en) 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
WO2013124436A1 (en) * 2012-02-23 2013-08-29 University Of East London Synthetic anti-microbial peptides with a minority of cationic and a majority hydrophobic side chains
JP6559066B2 (ja) 2012-10-30 2019-08-14 エスペランス ファーマシューティカルズ， インコーポレイテッド 抗体／薬剤結合体及び使用方法
GB201401877D0 (en) 2014-02-04 2014-03-19 Univ Tromsoe Peptides
US20170296629A1 (en) * 2014-10-08 2017-10-19 Keio University Inhibitor of extracellular trap formation in leukocyte
GB201810635D0 (en) * 2018-06-28 2018-08-15 Norut Northern Res Institute As Peptides and cancer treatment
CN111704652B (zh) * 2020-06-02 2022-04-22 昆明医科大学 一种抗光损伤皮肤保护活性多肽om-gl15及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547939A (en) * 1991-06-14 1996-08-20 The Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
EP0827511A1 (de) * 1995-04-05 1998-03-11 The Picower Institute For Medical Research Stoffe für die bindung an fortgeschritten glykosylierte endprodukte und verfahren für ihre verwendung
JP2001504447A (ja) * 1996-08-12 2001-04-03 エイプラス サイエンス インベスト アーベー ラクトフェリンおよび／またはラクトフェリシンでの、感染、炎症および／または腫瘍の処置および予防
JP2002515893A (ja) * 1997-02-03 2002-05-28 ファーミング インテレクチュアル プロパティ ビーブイ ヒトラクトフェリンおよびその改変体の有用な特性
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides

Also Published As

Publication number Publication date
ATE422502T1 (de) 2009-02-15
CA2382544A1 (en) 2001-03-22
US7393824B1 (en) 2008-07-01
WO2001019852A3 (en) 2002-09-12
EP1259536A2 (de) 2002-11-27
GB0005702D0 (en) 2000-05-03
AU781243B2 (en) 2005-05-12
CY1109450T1 (el) 2014-08-13
DK1259536T3 (da) 2009-06-08
NO20020950L (no) 2002-04-25
NO330170B1 (no) 2011-02-28
WO2001019852A2 (en) 2001-03-22
NO20020950D0 (no) 2002-02-27
AU6858700A (en) 2001-04-17
PT1259536E (pt) 2009-05-14
WO2001019852A8 (en) 2004-04-15
EP1259536B1 (de) 2009-02-11
ES2322228T3 (es) 2009-06-18
JP2003516931A (ja) 2003-05-20
JP4902919B2 (ja) 2012-03-21

Similar Documents

Publication Publication Date Title
CY1109450T1 (el) Μεθοδοι παρασκευης πεπτιδιων
CA2400295A1 (en) Modified factor viii
ATE380195T1 (de) Zusammensetzungen und verfahren zur behandlung von tumoren
CA2184908A1 (en) Human osteoclast-derived cathepsin
PT917571E (pt) Gene relacionado com agouti
BR0011500A (pt) Hialuronidase de hirudinaria manillensis, isolamento, purificação e método recombinante de produção
ATE444971T1 (de) Zusammensetzungen und verfahren für die tumor- behandlung
EP1118660A4 (de) Ein plasmaprotein-fragment erzeugendes enzym mit krebsmetastase-hemmender wirkung und durch dieses enzym fragmentiertes plasmaprotein-fragment
ATE427319T1 (de) Zusammensetzung und verfahren zur diagnose von tumoren
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
DE69524415T2 (de) UNGESPLEISSTE VARIANTEN DES gp350/220
WO2004094462A3 (en) Methods of peptide preparation
ATE309265T1 (de) Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt
WO2002029054A1 (fr) Nouvelle proteine, son procede de production et son utilisation
WO2001079432A3 (fr) Nouveau polypeptide, facteur humain de transcription de la differentiation cellulaire 58, et polynucleotide codant pour ce polypeptide
WO2001075012A3 (fr) Nouveau polypeptide, peptide signal humain 10 d'une proteine precurseur de la lipoproteine, et polynucleotide codant pour ce polypeptide
JP2002355060A5 (de)
WO2001075002A3 (fr) Nouveau polypeptide, gène de regulation du cycle cellulaire humain 28, et polynucléotide codant pour ce polypeptide
WO2001083682A3 (fr) Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide
MX9806628A (es) Gen de respuesta de diferenciacion terminal mieloide humana novedoso.
WO2001075007A3 (fr) Nouveau polypeptide, tyrosinase 15, et polynucléotide codant pour ce polypeptide
WO2002010380A1 (fr) Nouveau polypeptide, proteine a doigt de zinc de type kruppel zk110.12, et polynucleotide codant ce polypeptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803